When Michele Kerulis was diagnosed with breast cancer, she turned to UChicago Medicine experts for help. Rita Nanda, MD, offered Kerulis participation in a clinical trial testing the addition of an immunotherapy to standard chemotherapy for high-risk breast cancers. The cancer went into remission.
Many factors can increase a person's risk of developing cancer. At the University of Chicago Medicine, the Comprehensive Cancer Risk and Prevention Clinic is dedicated to identifying and caring for individuals who have an increased risk of cancer due to family history, or medical and genetic factors.
Specific strains of intestinal bacteria can improve the response rate to immunotherapy for patients being treated for advanced melanoma. Patients with a higher ratio of the “beneficial” bacteria to “non-beneficial” bacteria all showed a clinical response: a reduction in tumor size.